New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors
Keywords: پلی فسفات دینوکلئوزید; Antiplatelet therapy; Antithrombotics; Adenosine diphosphate; Cardiovascular disease; Acute coronary syndromes; P2Y1; P2Y12; P2X1; Dinucleoside polyphosphates; Bis-nucleoside polyphosphates; Inhibitors; PlateletsAp4A, P1,P4-di(adenosine-5′) tetraphosphate